Source: http://www.law.cornell.edu/cfr/text/21/866/subpart-G
Timestamp: 2013-05-21 13:22:27
Document Index: 576559028

Matched Legal Cases: ['art 866', '§ 866', '§ 866', '§ 866', '§ 866', '§ 866', '§ 360', '§ 360', '§ 360']

21 CFR 866, Subpart G - Tumor Associated Antigen immunological Test Systems | Title 21 - Food and Drugs | Code of Federal Regulations | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter H › Part 866 › Subpart G	prev | next
21 CFR 866, Subpart G - Tumor Associated Antigen immunological Test Systems
§ 866.6010 — Tumor-associated antigen immunological test system.
§ 866.6020 — Immunomagnetic circulating cancer cell selection and enumeration system.
§ 866.6030 — AFP-L3% immunological test system.
§ 866.6040 — Gene expression profiling test system for breast cancer prognosis.
§ 866.6050 — Ovarian adnexal mass assessment score test system.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeUSC : Title 21 - FOOD AND DRUGS§ 360c - Classification of devices intended for human use§ 360e - Premarket approval§ 360j - General provisions respecting control of devices intended for human use
Title 21 published on 2012-04-01The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR 866 after this date.2013-03-26; vol. 78 # 58 - Tuesday, March 26, 201378 FR 18233 - Medical Devices; Technical Amendment
United States district courts Resource Conservation and Recovery Act (RCRA)